The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

chosenmedtech.com

Stage

Series C - II | Alive

Total Raised

$23.55M

About ChosenMed

ChosenMed is a provider of oncology products and services, covering precision medicine solutions including early tumor screening, prevention and diagnosis, dynamic monitoring, medication guidance, prognostic evaluation, and bioinformatics big data analysis.

ChosenMed Headquarter Location

Building C3, Jinghai Industrial Park 156 Jinghai 4th Road, Beijing Economic and Technological Development Zone

Beijing, Beijing, 100176,

China

+86 (0)10 67865320

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ChosenMed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ChosenMed is included in 7 Expert Collections, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

B

Biopharma Tech

661 items

Latest ChosenMed News

ChosenMed of Beijing Completes B Round for Oncology Precision Medicine

Apr 22, 2020

publication date: Apr 22, 2020 ChosenMed Technology, a Beijing oncology precision medicine company, raised "hundreds of millions of yuan" in a Series B round led by Shanghai Lianhe Investment. The company offers products for early screening, prevention and diagnosis of tumors, dynamic monitoring, medication guidance, prognosis evaluation and bioinformatics data analysis. The company claims to have a complete industrial chain for its business, from upstream production of instruments and reagents, to mid-stream third-party oncology medical detection labs, and downstream genetic analysis and medical advice for patients. More details.... Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

ChosenMed Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ChosenMed Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.